Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.-Reference-Cited by-同舟云学术

Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.

Published:1998-05 Issue:6 Volume:31 Page:1414-1419
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Volgman Annabelle S,Carberry Peter A,Stambler Bruce,Lewis William R,Dunn George H,Perry Kimberly T,VanderLugt James T,Kowey Peter R

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter;Ellenbogen;J Am Coll Cardiol,1996

2. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation;Stambler;Circulation,1996

3. Effects of ibutilide fumarate, a new class III antiarrhythmic agent, in man [abstract];VanderLugt;Clin Pharmacol Ther,1991

4. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter;Kowey;Am J Cardiol,1996

5. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm;Halpern;Br Heart J,1980

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction;PLOS ONE;2024-08-19

2. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-06-03

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

5. Pharmacological cardioversion of atrial fibrillation: practical considerations;Polish Archives of Internal Medicine;2023-08-24